Kringle Pharma News

Kringle Pharma: Announcements of individual stock's financial estimates revision for September 2024 period.

Aug 9 02:40 ET

Kringle Pharma: Regarding the revision of the third quarter financial results and financial estimates for the September 2024 period.

Aug 9 02:40 ET

Kringle Pharma: September 2024 fiscal third quarter financial results announcement (Japanese standards) (non-consolidated)

Aug 9 02:40 ET

KRINGLE PHARMA: Q&A session on financial results briefing for the 2nd quarter of the fiscal year ending September 2024

May 20 03:20 ET

KRINGLE PHARMA: Financial results briefing materials for the 2nd quarter of the fiscal year ending 2024/9

May 17 03:00 ET

KRINGLE PHARMA: Summary of financial results for the 2nd quarter of the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)

May 13 02:40 ET

KRINGLE PHARMA: Quarterly Report - 23rd Quarter 2nd Quarter (2024/01/01 to 2024/03/31)

May 13 02:40 ET

KRINGLE PHARMA: Confirmation letter

May 13 02:40 ET

Kringle Pharma: Confirmation

Feb 9 01:41 ET

Kringle Pharma: Quarterly Report - 23rd Quarter 1st Quarter (2023/10/01 - 2023/12/31)

Feb 9 01:40 ET

Kringle Pharma: Explanatory materials on the top line data for the acute phase III trial of spinal cord injury and financial results for the 1st quarter of the fiscal year ending 2024/9

Feb 9 01:40 ET

Kringle Pharma: Summary of financial results for the 1st quarter of the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)

Feb 9 01:40 ET

Kringle Pharma: Extraordinary Report

Dec 25, 2023 02:24 ET

Kringle Pharma: Confirmation letter

Dec 25, 2023 02:23 ET

Kringle Pharma: Securities Report — 22nd Term (2022/10/01 - 2023/09/30)

Dec 25, 2023 02:20 ET

Kringle Pharma: Questions and answers on the full-year financial results briefing for the fiscal year ending September 2023

Nov 21, 2023 01:00 ET

Kringle Pharma: Full year financial results briefing materials for the fiscal year ending September 2023

Nov 20, 2023 02:35 ET

Kringle Pharma: Brief Financial Report for the Fiscal Year Ending September 2023 [Japanese GAAP] (unconsolidated)

Nov 13, 2023 01:40 ET

Kringle Pharma: Funding through financial results for the 3rd quarter of the fiscal year ending September 2023 and the 13th issue of stock acquisition rights

Aug 14, 2023 03:00 ET

Kringle Pharma: Confirmation letter

Aug 14, 2023 02:41 ET